Gossamer Bio Inc. (NASDAQ: GOSS) reported Q3 EPS of ($0.14), $0.01 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $9.48 million versus the consensus estimate of $8.53 million.

For earnings history and earnings-related data on Gossamer Bio Inc. (GOSS) click here.